AI in drug discovery

News

Isomorphic Labs has added to the lustre attached to its AI-powered drug discovery engine by raising an eye-watering $2.1 billion in a Series B round.

R&D

AI has begun to influence early-stage antibiotic discovery by identifying novel antibacterial compounds that are difficult to uncover traditionally.

News

AI start-up Profluent has signed a major alliance with pharma group Eli Lilly, worth up to $2.25bn, that will focus on gene-editing therapies.

News

MSD has agreed a deal with Google Cloud that will put the tech giant's AI tools in the hands of its 75,000 employees worldwide.

News

The first recipients of the UK government's £500 million Sovereign AI fund have been announced, including two life sciences-focused start-ups.

News

In this week's second AI model launch for life sciences research, OpenAI has introduced GPT-Rosalind, named after UK scientist Rosalind Franklin.